Other Viruses Citation List: July 5 - July 18, 2013

Hepatitis B Virus

1. Telbivudine and Adefovir Combination Therapy for Patients with Chronic Lamivudine-resistant Hepatitis B Virus Infections. Lin, M.T., Y.P. Chou, T.H. Hu, H.C. Yu, Y.C. Hsu, M.C. Tsai, P.L. Tseng, K.C. Chang, Y.H. Yen, and K.W. Chiu. Archives of Virology, 2013. [Epub ahead of print]; PMID[23857507].

[PubMed] OV_0705-071813.

2. Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral Protein. Mao, R., H. Nie, D. Cai, J. Zhang, H. Liu, R. Yan, A. Cuconati, T.M. Block, J.T. Guo, and H. Guo. Plos Pathogens, 2013. 9(7): p. e1003494; PMID[23853601].

[PubMed] OV_0705-071813.

3. Novel Artemisinin Derivatives with Potential Usefulness against Liver/Colon Cancer and Viral Hepatitis. Blazquez, A.G., M. Fernandez-Dolon, L. Sanchez-Vicente, A.D. Maestre, A.B. Gomez-San Miguel, M. Alvarez, M.A. Serrano, H. Jansen, T. Efferth, J.J. Marin, and M.R. Romero. Bioorganic & Medicinal Chemistry, 2013. 21(14): p. 4432-4441; PMID[23685181].

[PubMed] OV_0705-071813.

Hepatitis C Virus

4. Bastos, J.C.S.; Kohn, L.K.; Fantinatti-Garboggini, F.; Padilla, M.A.; Flores, E.F.; da Silva, B.P.; de Menezes, C.B.; and Arns, C.W. Antiviral Activity of Bacillus Sp. Isolated from the Marine Sponge Petromica Citrina against Bovine Viral Diarrhea Virus, a Surrogate Model of the Hepatitis C Virus. Viruses 2013, 5, 1219-1230. Bastos, J.C., L.K. Kohn, F. Fantinatti-Garboggini, M.A. Padilla, E.F. Flores, B.P. da Silva, C.B. de Menezes, and C.W. Arns. Viruses, 2013. 5(7): p. 1682-1683; PMID[23852269].

[PubMed] OV_0705-071813.

5. Structure-based Design of Novel HCV NS5B Thumb Pocket 2 Allosteric Inhibitors with Submicromolar gt1 Replicon Potency: Discovery of a Quinazolinone Chemotype. Beaulieu, P.L., R. Coulombe, J. Duan, G. Fazal, C. Godbout, O. Hucke, A. Jakalian, M.A. Joly, O. Lepage, M. Llinas-Brunet, J. Naud, M. Poirier, N. Rioux, B. Thavonekham, G. Kukolj, and T.A. Stammers. Bioorganic & Medicinal Chemistry Letters, 2013. 23(14): p. 4132-4140; PMID[23768906].

[PubMed] OV_0705-071813.

6. Synthesis and Optimization of a Novel Series of HCV NS3 Protease Inhibitors: 4-Arylproline Analogs. Bilodeau, F., M.D. Bailey, P.K. Bhardwaj, J. Bordeleau, P. Forgione, M. Garneau, E. Ghiro, V. Gorys, T. Halmos, E.S. Jolicoeur, M. Leblanc, C.T. Lemke, J. Naud, J. O'Meara, P.W. White, and M. Llinas-Brunet. Bioorganic & Medicinal Chemistry Letters, 2013. 23(14): p. 4267-4271; PMID[23735741].

[PubMed] OV_0705-071813.

7. High-throughput Profiling of IFNalpha and IL-28B Regulated Micrornas and Identification of let-7s with anti-HCV Activity by Targeting IGF2BP1. Cheng, M., Y. Si, Y. Niu, X. Liu, X. Li, J. Zhao, Q. Jin, and W. Yang. Journal of Virology, 2013. [Epub ahead of print]; PMID[23824794].

[PubMed] OV_0705-071813.

8. A Novel Promising Therapeutic Option against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir. Gentile, I., F. Borgia, A.R. Buonomo, G. Castaldo, and G. Borgia. Current Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23848533].

[PubMed] OV_0705-071813.

9. Restoration of the Activated Rig-I Pathway in HCV Replicon Cells by HCV Protease, Polymerase and NS5A Inhibitors in Vitro at Clinically Relevant Concentrations. Kalkeri, G., C. Lin, J. Gopilan, K. Sloan, R. Rijnbrand, and A.D. Kwong. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23836176].

[PubMed] OV_0705-071813.

10. Fetal Bovine Serum Inhibits Hepatitis C Virus Attachment to Host Cells. Qin, Z.L., H.P. Ju, Y. Liu, T.T. Gao, W.B. Wang, L. Aurelian, P. Zhao, and Z.T. Qi. Journal of Virological Methods, 2013. [Epub ahead of print]; PMID[23845899].

[PubMed] OV_0705-071813.

11. Primuline Derivatives That Mimic RNA to Stimulate Hepatitis C Virus NS3 Helicase-Catalyzed ATP Hydrolysis. Sweeney, N.L., W.R. Shadrick, S. Mukherjee, K. Li, K.J. Frankowski, F.J. Schoenen, and D.N. Frick. The Journal of Biological Chemistry, 2013. 288(27): p. 19949-19957; PMID[23703611].

[PubMed] OV_0705-071813.

Human Cytomegalovirus

12. A Peptide Inhibitor of Cytomegalovirus Infection from Human Hemofiltrate. Borst, E.M., L. Standker, K. Wagner, T.F. Schulz, W.G. Forssmann, and M. Messerle. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]; PMID[23856778].

[PubMed] OV_0705-071813.

13. Synthesis and anti-HCMV Activity of 1-[omega-(Phenoxy)alkyl]uracil Derivatives and Analogues Thereof. Novikov, M.S., D.A. Babkov, M.P. Paramonova, A.L. Khandazhinskaya, A.A. Ozerov, A.O. Chizhov, G. Andrei, R. Snoeck, J. Balzarini, and K.L. Seley-Radtke. Bioorganic & Medicinal Chemistry, 2013. 21(14): p. 4151-4157; PMID[23743443].

[PubMed] OV_0705-071813.

Epstein-Barr Virus

14. Hsp90 Inhibitor 17-DMAG Decreases Expression of Conserved Herpesvirus Protein Kinases and Reduces Virus Production in Epstein-Barr Virus-infected Cells. Sun, X., J.A. Bristol, S. Iwahori, S.R. Hagemeier, Q. Meng, E.A. Barlow, J.D. Fingeroth, V.L. Tarakanova, R.F. Kalejta, and S.C. Kenney. Journal of Virology, 2013. [Epub ahead of print]; PMID[23843639].

[PubMed] OV_0705-071813.

15. PI3Kdelta Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein-Barr Virus (EBV)+ B Cell Lymphomas. Furukawa, S., L. Wei, S.M. Krams, C.O. Esquivel, and O.M. Martinez. American Journal of Transplantation, 2013. [Epub ahead of print]; PMID[23841834].

[PubMed] OV_0705-071813.

16. 6'-Methyl-5'-homoaristeromycin: A Structural Variation of the Anti-orthopox Virus Candidate 5'-Homoaristeromycin. Yang, M., W. Ye, and S.W. Schneller. Bioorganic & Medicinal Chemistry, 2013. 21(14): p. 4374-4377; PMID[23727195].

[PubMed] OV_0705-071813.

Citations from the ISI Web of Knowledge Listings for O.V.

17. Different Molecular Mechanisms of Inhibition of Bovine Viral Diarrhea Virus and Hepatitis C Virus RNA-dependent RNA Polymerases by a Novel Benzimidazole. Asthana, S., S. Shukla, A.V. Vargiu, M. Ceccarelli, P. Ruggerone, G. Paglietti, M.E. Marongiu, S. Blois, G. Giliberti, and P. La Colla. Biochemistry, 2013. 52(21): p. 3752-3764; ISI[000319795500017].

[WOS] OV_0705-071813.

18. Rapid and Convenient Assays to Assess Potential Inhibitory Activity on in Vitro Hepatitis a Replication. Debing, Y., G.G. Kaplan, J. Neyts, and D. Jochmans. Antiviral Research, 2013. 98(2): p. 325-331; ISI[000319711900023].

[WOS] OV_0705-071813.

19. A Novel Monoclonal anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission. Fofana, I., F. Xiao, C. Thumann, M. Turek, L. Zona, R.G. Tawar, F. Grunert, J. Thompson, M.B. Zeisel, and T.F. Baumert. Plos One, 2013. 8(5): p. e64221; ISI[000319330200125].

[WOS] OV_0705-071813.

20. Inhibition of Calmodulin-dependent Kinase Kinase Blocks Human Cytomegalovirus-induced Glycolytic Activation and Severely Attenuates Production of Viral Progeny (Vol 85, Pg 705, 2011). McArdle, J., X.L. Schafer, and J. Munger. Journal of Virology, 2013. 87(12): p. 7197-7197; ISI[000319508600064].

[WOS] OV_0705-071813.

21. Effect of Baicalein on the Expression of VIP in Extravillous Cytotrophoblasts Infected with Human Cytomegalovirus in Vitro. Qiao, Y., J.G. Fang, J. Xiao, T. Liu, J. Liu, Y.L. Zhang, and S.H. Chen. Journal of Huazhong University of Science and Technology-Medical Sciences, 2013. 33(3): p. 406-411; ISI[000320511400016].

[WOS] OV_0705-071813.

22. All-oral HCV Therapies near Approval. Tse, M.T. Nature Reviews Drug Discovery, 2013. 12(6): p. 409-U17; ISI[000319739200002].

[WOS] OV_0705-071813.

23. A Herpes Simplex Virus Scaffold Peptide That Binds the Portal Vertex Inhibits Early Steps in Viral Replication. Yang, K., E. Wills, and J.D. Baines. Journal of Virology, 2013. 87(12): p. 6876-6887; ISI[000319508600032].

[WOS] OV_0705-071813.